{"organizations": [], "uuid": "7cf4157562f4d8a04f521ed8ba14a258b63da787", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180118.html", "section_title": "Archive News &amp; Video for Thursday, 18 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-fda-commissioner-issues-statement/brief-fda-commissioner-issues-statement-on-new-policy-steps-for-public-warning-and-notification-of-recalls-idUSFWN1PD1ET", "country": "US", "domain_rank": 408, "title": "BRIEF-FDA Commissioner Issues Statement On New Policy Steps For Public Warning And Notification Of Recalls", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-19T04:44:00.000+02:00", "replies_count": 0, "uuid": "7cf4157562f4d8a04f521ed8ba14a258b63da787"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-fda-commissioner-issues-statement/brief-fda-commissioner-issues-statement-on-new-policy-steps-for-public-warning-and-notification-of-recalls-idUSFWN1PD1ET", "ord_in_thread": 0, "title": "BRIEF-FDA Commissioner Issues Statement On New Policy Steps For Public Warning And Notification Of Recalls", "locations": [], "entities": {"persons": [{"name": "scott gottlieb", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "public warning and notification of recalls", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 18 (Reuters) - FDA COMMISSIONER SCOTT GOTTLIEB :\n* FDA COMMISSIONER SCOTT GOTTLIEB ISSUES STATEMENT ON NEW POLICY STEPS FOR STRENGTHENING PUBLIC WARNING AND NOTIFICATION OF RECALLS\n* FDA COMMISSIONER SAYS DRAFT GUIDANCE OUTLINES CIRCUMSTANCES WHEN A COMPANY SHOULD ISSUE A PUBLIC WARNING ABOUT A RECALL\n* FDA COMMISSIONER SAYS DEVELOPING NEW FDA POLICY ON WHAT INFORMATION FDA WILL MAKE AVAILABLE TO HELP PUBLIC IDENTIFY HAZARDOUS RECALLED FOOD\n* FDA COMMISSIONER SAYS GUIDANCE ALSO DESCRIBES GENERAL TIMELINE FOR COS TO ISSUE RECALL WARNING, DISCUSSES WHAT INFO SHOULD BE ADDED IN PUBLIC WARNING Source text : ( bit.ly/2DoCn0K )\n ", "external_links": ["http://bit.ly/2DoCn0K", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-19T04:44:00.000+02:00", "crawled": "2018-01-19T12:19:50.004+02:00", "highlightTitle": ""}